Sivelestat relaxes porcine coronary artery via inhibition of Ca 2+ sensitization induced by a receptor agonist

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 5, 2008, Pages 476-482

  Maeda, Yoshinori ^a   Mitsumizo, Shinji ^a   Guo, Fengling ^b   Kishi, Hiroko ^b   Matsuo, Sayaka ^b   Kobayashi, Sei ^b   Nakashima, Mikio ^a  

^a SAGA UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ca2+ sensitivity; Coronary artery; Smooth muscle; Vasorelaxation; Vasospasm

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BETA ESCIN; CALCIUM; GUANOSINE TRIPHOSPHATE; SIVELESTAT; DRUG DERIVATIVE; GLYCINE; SULFONAMIDE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CALCIUM CELL LEVEL; CELL PH; CORONARY ARTERY; CYTOSOL; DRUG EFFECT; HEART CONTRACTION; HEART MUSCLE; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR SMOOTH MUSCLE; VASODILATATION; ANIMAL; CORONARY BLOOD VESSEL; IN VITRO STUDY; METABOLISM; MUSCLE ISOMETRIC CONTRACTION; MUSCLE RELAXATION; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CALCIUM; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; GLYCINE; ISOMETRIC CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; SULFONAMIDES; SWINE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 55949117936     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31816b8c9a     Document Type: Article

References (28)

1. Kawabata K, Hagio T, Matsumoto S, et al. Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am J Respir Crit Care Med. 2000; 161:2013-2018.
2. Yamazaki T, Ooshima H, Usui A, et al. Protective effects of ONO-5046·Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury. Ann Thorac Surg. 1999;68:2141-2146.
3. Tomizawa N, Ohwada S, Ohya T, et al. The effects of a neutrophil elastase inhibitor (ONO-5046·Na) and neutrophil depletion using a granulotrap (G-1) column on lung reperfusion injury in dogs. J Heart Lung Transplant. 1999;18:637-645.
4. Carden D, Xiao F, Moak C, et al. Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. Am J Physiol. 1998;275:H385-H392.
5. Petty TL. Protease mechanisms in the pathogenesis of acute lung injury. Ann N Y Acad Sci. 1991;624:267-277.
6. Smedly LA, Tonnesen MG, Sandhaus RA, et al. Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest. 1986;77:1233-1243.
7. Maseri A, Severi S, Nes MD, et al. "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol. 1978;42:1019-1035.
8. Thadani U, Rodgers T. Side effects of using nitrates to treat angina. Expert Opin Drug Saf. 2006;5:667-674.
9. Furberg CD, Psaty BM, Meyer JV Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92: 1326-1331.
10. 2+-sensitization of vascular smooth muscle contraction: possible involvement of rho-kinase. FEBS Lett. 2000;482: 85-90.
11. Mitsumizo S, Nakashima M, Hamada T, et al. NOS II inhibition restores attenuation of endothelium-dependent hyperpolarization in rat mesenteric artery exposed to lipopolysaccharide. J Cardiovasc Pharmacol. 2004;43: 589-594.
12. 2+-sensitivity in pig coronary arterial smooth muscle. Biochem Biophys Res Commun. 1995;212: 572-579.
13. Kuroiwa M, Aoki H, Kobayashi S, et al. Role of GTP-protein and endothelium in contraction induced by ethanol in pig coronary artery. J Physiol. 1993;470:521-537.
14. 2+]i in porcine coronary artery smooth muscle. Circ Res. 1994;75:990-998.
15. 2+ release in smooth muscle. Physiological role of inositol 1,4,5-trisphosphate in pharmacomechanical coupling. J Biol Chem. 1989;264:17997-18004.
16. 2+ sensitivity in alpha-toxin permea-bilized arterial smooth muscle. Biochem Biophys Res Commun. 1988;157: 677-683.
17. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature. 1994;372:231-236.
18. Shepherd JT, Vanhoutte PM. Spasm of the coronary arteries: causes and consequences (the scientist's viewpoint). Mayo Clin Proc. 1985;60:33-46.
19. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992; 326:242-250.
20. Hillis LD, Braunwald E. Coronary-artery spasm. N Engl J Med. 1978;299: 695-702.
21. 2+ sensitization of coronary artery contraction mediated by a sphingosylphosphorylcholine-Rho-kinase pathway. Circ Res. 2002;91:953-960.
22. Feldman RL. A review of medical therapy for coronary artery spasm. Circulation. 1987;75:V96-V102.
23. Takayama N, Uchida K. Epithelium-dependent and -independent inhibitory effects of sivelestat, a neutrophil elastase inhibitor, on substance P-induced contraction of airway smooth muscle in lipopolysaccharide-treated guinea-pigs. J Smooth Muscle Res. 2005;41:257-270.
24. Chao J, Stallone JN, Liang YM, et al. Kallistatin is a potent new vasodilator. J Clin Invest. 1997;100:11-17.
25. Wray S. Smooth muscle intracellular pH: measurement, regulation, and function. Am J Physiol. 1988;254:C213-C225.
26. Bowman P, Haikala H, Paul RJ. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization. J Pharmacol Exp Ther. 1999;288:316-325.
27. Tamakuma S, Shiba T, Hirasawa H, et al. Early phase II clinical study of a neutrophil elastase inhibitor; ONO-5046? Na in sepsis patients [in Japanese]. J Clin Ther Med. 1998;14:241-261.
28. Miura M, Ito S, Baba E, et al. A Clinical Pharmacological Study of a Neutrophil Elastase Inhibitor; ONO-5046·Na in SIRS Patients [in Japanese]. J Clin Ther Med. 1998;14:379-395.